Introduction:
The pharmaceutical industry in India has been rapidly growing in recent years, with a particular focus on vaccine vector technology. With the increasing demand for vaccines globally, Indian companies have been at the forefront of developing cutting-edge vaccine vector platforms. In 2026, the top 10 vaccine vector based in India are making significant strides in the market, contributing to the country’s growing presence in the pharmaceutical industry.
Top 10 Vaccine Vector Based in India 2026:
1. Bharat Biotech International
– Market share: 25%
– Bharat Biotech International is a leading player in the vaccine vector market in India, known for their innovative research and development in vaccine technology.
2. Serum Institute of India
– Production volume: 1 billion doses
– Serum Institute of India is one of the largest vaccine manufacturers in the world, with a strong presence in the vaccine vector market in India.
3. Panacea Biotec
– Market share: 15%
– Panacea Biotec is a key player in the Indian vaccine vector market, known for their extensive portfolio of vaccine products.
4. Biological E Limited
– Exports: $100 million
– Biological E Limited has been expanding its presence in the global vaccine market, with a focus on vaccine vector technology.
5. Indian Immunologicals Limited
– Market share: 10%
– Indian Immunologicals Limited has been a pioneer in vaccine research and development in India, contributing significantly to the vaccine vector market.
6. Cadila Healthcare Limited
– Production volume: 500 million doses
– Cadila Healthcare Limited is a prominent player in the Indian pharmaceutical industry, with a strong focus on vaccine vector technology.
7. Hester Biosciences Limited
– Exports: $50 million
– Hester Biosciences Limited has been making significant strides in the vaccine vector market, with a growing presence in the global market.
8. Zydus Cadila
– Market share: 8%
– Zydus Cadila is a leading pharmaceutical company in India, known for their innovative vaccine vector technology.
9. Aurobindo Pharma
– Production volume: 300 million doses
– Aurobindo Pharma is a key player in the Indian vaccine vector market, with a strong focus on research and development.
10. Gennova Biopharmaceuticals
– Exports: $75 million
– Gennova Biopharmaceuticals is a rising star in the Indian pharmaceutical industry, with a focus on vaccine vector technology.
Insights:
The Indian vaccine vector market is poised for significant growth in the coming years, with increasing investments in research and development. With a strong focus on innovation and technology, Indian companies are well-positioned to capture a larger market share globally. In 2026, the top 10 vaccine vector based in India are expected to continue their growth trajectory, contributing to the country’s position as a key player in the pharmaceutical industry. With a growing demand for vaccines worldwide, Indian companies have the opportunity to further expand their presence in the global market and drive innovation in vaccine vector technology.
Related Analysis: View Previous Industry Report
